VentriFlo
Founded Year
2019Stage
Series A | AliveTotal Raised
$10MLast Raised
$10M | 3 yrs agoAbout VentriFlo
The VentriFlo True Pulse Pump is a pulsatile blood pumping system designed to achieve superior outcomes, reduce costs and improve safety for pediatric and adult patients who require cardiopulmonary support during surgery or in the ICU.
Missing: VentriFlo's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: VentriFlo's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing VentriFlo
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
VentriFlo is included in 2 Expert Collections, including Medical Devices.
Medical Devices
8,606 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items
VentriFlo Patents
VentriFlo has filed 6 patents.
The 3 most popular patent topics include:
- Linear motor metros
- Pumps
- Fluid dynamics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/23/2021 | 1/10/2023 | Pumps, Fluid dynamics, Marine diesel engines, Diesel locomotive engines, Congenital heart defects | Grant |
Application Date | 2/23/2021 |
|---|---|
Grant Date | 1/10/2023 |
Title | |
Related Topics | Pumps, Fluid dynamics, Marine diesel engines, Diesel locomotive engines, Congenital heart defects |
Status | Grant |
Latest VentriFlo News
Sep 20, 2019
VentriFlo, Inc. , a Pelham, N.H.-based developer of a a blood pumping platform, closed a $10m Series A funding. The round was led by Jim and Pat Poitras and other investors. The company intends to use the funds to continue the development and FDA 510(k) submission for its patented platform. Led by Doug Vincent, President & CEO, VentriFlo is advancing tre VentriFlo® True Pulse Pump™, which is capable of replicating the native heartbeat by delivering blood flow with a life-like pulse during surgery or in the ICU. VentriFlo True Pulse Pumps are under development, for investigational use only, and are not available for commercial sale. The company was originated from Design Mentor, Inc., a NH corporation with a history of medical device design and development, specializing in fluid pumping. FinSMEs
VentriFlo Frequently Asked Questions (FAQ)
When was VentriFlo founded?
VentriFlo was founded in 2019.
Where is VentriFlo's headquarters?
VentriFlo's headquarters is located at 70 Bridge St, Pelham.
What is VentriFlo's latest funding round?
VentriFlo's latest funding round is Series A.
How much did VentriFlo raise?
VentriFlo raised a total of $10M.
Who are the investors of VentriFlo?
Investors of VentriFlo include Jim Poitras and Pat Poitras.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.